Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Dosing interval of natalizumab in MS: Do good things come to those who wait?
David B. Clifford
, Kenneth L. Tyler
Department of Neurology
Institute of Clinical and Translational Sciences (ICTS)
Section of Neuroinfectious Disease
Research output
:
Contribution to journal
›
Editorial
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dosing interval of natalizumab in MS: Do good things come to those who wait?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically